Alight's revenue has contracted from $548.0M in 2025Q1 to $500.0M in 2026Q3, while gross margin compressed from 39.9% in 2024Q4 to 27.0% in 2026Q3, suggesting structural rather than cyclical pressure.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 3, 2026 | $0.66+435.7% vs $0.12 | $500M+5.5% vs $474M |
Q3 2026 Aug 4, 2026 | $0.91+20.2% vs $0.76 | $511M+2.8% vs $497M |
Q2 2026 May 5, 2026 | $1.20+43.0% vs $0.84 | $534M+6.2% vs $503M |
Q1 2026 Feb 19, 2026 | $3.60-22.1% vs $4.62 | $653M-0.3% vs $655M |
Alight remains a 'Sell' despite a recent Q3 earnings beat and a 15% rally, as revenue continues to decline sharply. ALIT trades at 10.4x EV/FY26 adjusted EBITDA, but quality concerns outweigh valuation arguments, with gross margins below 30%. Retention issues persist, and management guides to a -6% y/y revenue decline for FY26, undermining any rebound thesis.
Alight, Inc. (ALIT) Q3 2026 Earnings Call Transcript
CHICAGO--(BUSINESS WIRE)--Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth and leave solutions, today reported results for the third quarter ended September 30, 2026. Rohit Verma, Chief Executive Officer of Alight, commented, “We are pleased to have surpassed revenue and adjusted EBITDA expectations for the third consecutive quarter, reflecting our continued execution of our long-term strategy to bolster Alight's leadership position in the market and retur.
DEERFIELD, Ill.--(BUSINESS WIRE)--Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth and leave solutions, today announced a new health reimbursement account (HRA) that helps employers offer financial support to their employees for eligible GLP-1 medications, while enabling more control over program costs and design.The Alight GLP-1 HRA gives employers another way to support employees as they incorporate GLP-1 medications into their broader health and benefits.
Benchmark ALIT against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Alight, Inc. (ALIT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $12.86 | $338.76M | -0.34 | -3% | -46.04% | -99.17% | 25.35% | |
| $328.86 | $31.06B | 19.77 | -2.24% | 15.22% | 19.72% | 1.1% | |
| $204.82 | $97.74B | 24.28 | 10.32% | 14.2% | 26.73% | 1.69% | |
| $334.81 | $71.02B | 18.14 | 9.45% | 22.24% | 39.91% | 0.87% | |
| $79.15 | $2B | 19.63 | 2.52% | 3.25% | 10.89% | 0.75% | |
| $303.35 | $121.26B | 26.65 | 6.74% | 20.33% | 75.85% | 2.17% |
Alight, Inc. (ALIT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Alight, Inc. (ALIT) SEC filings — annual & quarterly reports (10-K, 10-Q)
Nov 3, 2026·SEC
Oct 14, 2026·SEC
Aug 4, 2026·SEC
Get notified when ALIT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Alight, Inc. (ALIT) stock FAQ — growth, dividends, profitability & financials explained
Alight, Inc. (ALIT) reported $2.20B in revenue over the trailing twelve months. Revenue was $2.26B in fiscal year 2025. That is 2% less than the $2.30B of fiscal year 2017.
Alight, Inc. (ALIT) revenue fell by 4.0% over the trailing twelve months, compared with the twelve months before.
No. Alight, Inc. (ALIT) reported a net loss of $1.01B over the trailing twelve months.
Yes. Alight, Inc. (ALIT) pays a dividend that yields 25.35% at the current price, a high yield.
Alight, Inc. (ALIT) had a return on equity (ROE) of -99.2% over the trailing twelve months. A negative ROE means the company lost money over the period.
Alight, Inc. (ALIT) generated $207.0M in free cash flow over the trailing twelve months.
